| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 35.10B | 34.70B | 38.09B | 36.12B | 34.16B |
| Gross Profit | 3.59B | 3.54B | 3.41B | 3.82B | 3.53B | 3.19B |
| EBITDA | 3.37B | 3.33B | 3.10B | 3.65B | 3.38B | 2.85B |
| Net Income | 1.22B | 1.13B | 980.00M | 1.27B | 1.13B | 803.00M |
Balance Sheet | ||||||
| Total Assets | 50.52B | 50.99B | 48.44B | 46.31B | 47.58B | 42.90B |
| Cash, Cash Equivalents and Short-Term Investments | 3.91B | 4.89B | 2.66B | 2.92B | 3.83B | 3.29B |
| Total Debt | 16.08B | 16.25B | 14.06B | 14.89B | 16.55B | 12.14B |
| Total Liabilities | 22.79B | 23.46B | 21.88B | 22.42B | 24.70B | 21.06B |
| Stockholders Equity | 27.54B | 27.35B | 26.40B | 23.74B | 22.73B | 21.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -821.00M | 951.00M | -100.00M | -3.22B | 686.00M |
| Operating Cash Flow | 0.00 | 2.15B | 2.60B | 4.18B | 2.79B | 2.48B |
| Investing Cash Flow | 0.00 | -2.22B | -1.10B | -4.18B | -5.94B | -1.79B |
| Financing Cash Flow | 0.00 | 2.29B | -1.76B | -945.00M | 3.68B | 383.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.18B | 8.60 | ― | 3.04% | 4.45% | 29.58% | |
73 Outperform | ¥15.43B | 7.26 | ― | 3.85% | 4.96% | 38.47% | |
73 Outperform | ¥79.78B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
68 Neutral | ¥76.54B | 9.20 | ― | 3.63% | 2.67% | 18.02% | |
67 Neutral | ¥310.21B | 19.07 | ― | 2.94% | 4.50% | 82.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥315.29B | 20.24 | ― | 1.28% | 8.11% | -9.27% |